Showing results (91-100 of 140) with videos related to
Sort By:
Pageof 14
Neuron|June 6, 2000
Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degenerationT Harada, C Harada, N Nakayama, et al.Hepato-Gastroenterology|October 26, 2002
Epithelioid hemangioendothelioma of the liver associated with thrombocytopenia and coagulopathyH Imanishi, M Kawata, M Yanagihara, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 2006
Evidence for white matter disruption in traumatic brain injury without macroscopic lesionsN Nakayama, A Okumura, J Shinoda, et al.Hepato-Gastroenterology|May 1, 1997
Surgical risks of acute cholecystitis in elderlyY Tokunaga, N Nakayama, Y Ishikawa, et al.The Japanese Journal of Antibiotics|December 1, 1992
[Pharmacokinetic and clinical studies of cefprozil fine granules in children]K Nagano, H Maeda, T Yanagi, et al.The Journal of Antibiotics|January 1, 1994
Cyclothialidine, a novel DNA gyrase inhibitor. II. Isolation, characterization and structure elucidationT Kamiyama, N Shimma, T Ohtsuka, et al.Clinical and Experimental Obstetrics & Gynecology|November 29, 2013
Surgical treatment outcomes of serious chronic tubo-ovarian abscess: a single-center series of 20 casesK Nakayama, M Ishikawa, H Katagiri, et al.Scandinavian Journal of Gastroenterology|November 4, 2000
Mannose-binding lectin polymorphisms in patients with hepatitis C virus infectionK Sasaki, A Tsutsumi, N Wakamiya, et al.British Journal of Cancer|November 20, 2008
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancerN Nakayama, K Nakayama, S Yeasmin, et al.Nihon Geka Gakkai Zasshi|January 1, 1985
[An in vitro sensitivity assay of anti-cancer agents by measuring the inhibition rate of DNA synthesis (3H-thymidine uptake) of cancer cells--clinical study]Y Nio, T Inamoto, K Ohgaki, et al.Pageof 14